Featured News | Vanrx

Vanrx Pharmasystems introduces the Dynamic Peristaltic Pump

March 18, 2020 - Featured

“The required dosage for many advanced therapies is very low—sometimes 0.5 mL or less. Getting the highest yield from your batch is essential, since each additional dosage treats another patient. Current and future customers will be able to serve their patients better thanks to the new Dynamic Peristaltic Pump,” explains Chris Procyshyn, CEO and co-founder of Vanrx.

Hands off the goods

March 5, 2020 - Article, Featured

Vanrx CEO Chris Procyshyn writes in the latest issue of The Medicine Maker how adopting closed, automated aseptic processing systems is a crucial step to bring 21st century therapies to patients.

Collaboration at work with FUJIFILM Diosynth Biotechnologies

December 17, 2019 - Featured

When looking for a new fill-finish solution for its gene therapy manufacturing operations, CDMO FUJIFILM Diosynth Biotechnologies turned to isolator technology offered by Vanrx Pharmasystems. Thomas Page, Vice President, Engineering and Asset Development, was interviewed by the editor of The Medicine Maker about their experience working with Vanrx.


What do NGS and CRISPR-Cas9 mean for the future of drug products?

The transition from blanket therapeutic approaches to customized treatments for a single patient is referred to as precision medicine. This article discusses two scientific tools and how they influence the future of precision medicine: Next-generation sequencing (NGS) and CRISPR-Cas9.

December 18, 2018 - Blog, Featured

Roche presents on the role of robotics in their manufacturing strategy

On November 6 at AAPS, Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation described how Roche / Genentech will use Vanrx's SA25 as part of a "network" strategy.

November 22, 2018 - Featured, News

Bring new drug products to market faster

In a 2018 interview, Esteban Santos, executive VP for operations at Amgen, described how pharmaceutical companies need to accelerate drug development, build facilities faster and respond faster to changing market conditions. This blog will explore how Vanrx’s aseptic processing machines can help achieve these goals.

October 15, 2018 - Blog, Featured

Manual aseptic processing needs to end

Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.

September 7, 2018 - Blog, Featured

Smoothing the path to isolator adoption for aseptic filling

In March 2018, data from surveys presented at ISPE Aseptic and PDA Annual Meeting provides important insights into aseptic filling methods. Pharma companies state that there are significant obstacles to adopt isolators or RABS. Vanrx suggests that these obstacles are avoided by adopting fully robotic gloveless isolators.

August 1, 2018 - Article, Blog, Featured

Robotics in pharmaceutical manufacturing

In 2010, our CEO Chris Procyshyn ‘wrote the book’ on the use of robotics in pharmaceutical manufacturing. In this blog, we look at his chapter “Isolated Robotics” in the publication Advanced Aseptic Processing Technology and review where Vanrx stands today on the use of robotics.

July 13, 2018 - Article, Blog, Featured

Vanrx hosts first collaborative User Group meeting

Vanrx recently hosted its first User Group meeting, with customers and members of the Matrix Alliance partnership, coming to Whistler for two days of collaborative discussion. The goal being to share information and strategies regarding the implementation of Vanrx’s Aseptic Filling Workcells.

June 18, 2018 - Featured, News

Vanrx Microcell wins Interphex ‘Best in Show’ award

Vanrx Pharmasystems’ Microcell Vial Filler has won the ‘Best in Show’ award at Interphex 2018, which "recognizes accomplishments and display in the use of knowledge, innovation, and state-of-the-art technologies to achieve extraordinary levels of quality, production goals, and objectives.”

April 18, 2018 - News

White paper: Aseptic filling for personalized medicines

Vanrx Pharmasystems has released Aseptic Filling for Personalized Medicines, a white paper that reviews how new agile filling technology can change the manufacturing of cell & gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.

February 16, 2018 - Uncategorized

Aseptic filling for viral vector therapies

Gene therapies and other personalized medicines delivered using viral vectors have the ability to reach cells without detection and enable the therapeutic “payload” to pass through the cell’s walls. These are sometimes described as “cruise missiles for (insert disease name here).”

January 29, 2018 - Blog

Infographic: Flexible aseptic filling is easier with Vanrx

Many companies are considering flexible aseptic filling machines as they build manufacturing capacity for new injectable therapies. The challenge is to make multiple products, delivered in a wider array of formats. Learn how Vanrx defines flexibility and why modularity does not equal flexibility.

January 16, 2018 - Featured

Vanrx introduces the Microcell Vial Filler

Vanrx is introducing the Microcell Vial Filler, a new gloveless robotic isolator for aseptic filling. The Microcell is focused on clinical trial production and development of sterile injectable biopharmaceuticals, cell therapies and personalized medicines.

September 11, 2017 - Featured, News

Vanrx appoints Shreedhar Instruments as its distributor in India

Shreedhar Instruments has become Vanrx's exclusive distributor in India. The company has extensive coverage across all of India's pharmaceutical manufacturing centres, and an excellent reputation amongst the country's leading companies. New business partnership brings robotic aseptic filling systems to Indian pharmaceutical market.

June 4, 2017 - Featured, News

Automation & Drives India: Advancing Through Robotic Automation

Market forces are changing the pharmaceutical industry and forcing manufacturers to adopt more flexible methods of production. The article details how India’s pharmaceutical industry is advancing through robotic automation within a gloveless isolator for the production of sterile injectables.

May 24, 2017 - Featured, News

White paper: A New Paradigm for Manufacturing Injectable Medicines

Vanrx's white paper “A New Paradigm for Manufacturing Injectable Medicines” details a solution that supports the flexible production of parenteral drug products. This solution resolves long-standing issues in aseptic production, while enabling manufacturers to bring drug products to market faster.

November 1, 2016 - Uncategorized

Singota™ Solutions Announces Selection of Vanrx Aseptic Filling Equipment

Singota Solutions has selected Vanrx Pharmasystems’ SA25 Aseptic Filling Workcell to provide the company’s new filling capability. Singota chose the Vanrx technology for its manufacturing flexibility and the exceptional drug product quality that it can deliver to pharmaceutical companies making injectable medicines.

July 20, 2016 - News

Vanrx introduces quality assurance technology

A new vision targeting system was introduced at the Parenteral Drug Association’s (PDA) "The Universe of Pre-filled Syringes and Injection Devices" conference. This revolutionary technology inspects nested vials, cartridges, syringes, and their corresponding closures, to provide a more accurate, cost-effective and efficient filling process.

November 3, 2015 - News


Interphex 2021

Apr 20 - Apr 22 2021

New York, NY, USA


Jun 14 - Jun 18 2021

Frankfurt am Main, Germany

ISPE Boston Product Show

Sep 15 - Sep 15 2021

Foxborough, MA, USA